®™
August 3, 2012
February 2, 2012
UBC Dairy Centre Research Reports, Vol 12 No 1.
January 24, 2012
Merck Animal Health Enters Public-Private Partnership to Develop Innovative Strategies to Complement Bovine Mastitis Treatment
BOXMEER (The Netherlands) – Merck Animal Health (known as MSD Animal Health outside the USA and Canada) today announces that it has signed an agreement with the Department of Medical Microbiology of the University Medical Center (UMC) Utrecht and the Faculty of Veterinary Medicine of Utrecht University to embark on the development of innovative vaccination […]
More ...December 23, 2011
11th International Colloquium on Paratuberculosis: Sydney Australia. February 5-10, 2011.
January 13, 2010
symposium shows importance of MANAGING Bovine Respiratory Disease ‘right the first time’ WITH COMBINATION TREATMENT
BOXMEER (Netherlands), January 13, 2010 – Treatment of Bovine Respiratory Disease (BRD) in cattle with a combination preparation consisting of the anti-infective drug florfenicol and the anti-inflammatory drug flunixin meglumine (RESFLOR® Solution for Injection), results in control of bacterial growth, reduction of fever and reduction of lung consolidation. This conclusion was drawn last month at […]
More ...Next page ...
Ropapharm international
Ropapharm germany